TRCQT reduced brain infarct volume and improved neurological outcomes by reducing apoptosis, attenuating the expression of TNF-α and p-JNK, and reducing the formation of HO· radicals in MCAO-induced embolic stroke of rats. This evidence concerns the gene TNF and stroke disorder.